Search results
Showing 46 to 60 of 80 results for aneurysm
Comes from guidance Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management Number NG228 Date issued
Comes from guidance Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management Number NG228 Date issued
Comes from guidance Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management Number NG228 Date issued
Comes from guidance Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management Number NG228 Date issued
Negative pressure wound therapy for the open abdomen (HTG321)
Evidence-based recommendations on negative pressure wound therapy for the open abdomen. This involves using a small pump to remove infected material, stop fluid escaping and help the wound heal.
Summary of the evidence on antimicrobial prescribing: delafloxacin
NICE encourages research into endovascular stentgrafting of popliteal aneurysms and may review this procedure on publication of further...
Evidence-based recommendations on transcervical extracorporeal reverse flow neuroprotection for reducing the risk of stroke during carotid artery stenting in adults. This involves reversing blood flow away from the brain and filtering the blood to remove any debris.
Laser-assisted cerebral vascular anastomosis without temporary arterial occlusion (HTG161)
Evidence-based recommendations on laser-assisted cerebral vascular anastomosis without temporary arterial occlusion. This involves using a special laser device to create a bypass without the need to temporarily interrupt the blood flow to the brain.
View recommendations for HTG161Show all sections
Sections for HTG161
intrasaccular wire-mesh blood-flow disruption device for intracranial aneurysms is adequate to support the use of this procedure...
Find out which guidance and quality standards are awaiting development
Supraorbital minicraniotomy for intracranial aneurysm (IPG84)
We have moved interventional procedures guidance 84 to become HealthTech guidance 52. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Chronic heart failure in adults: diagnosis and management (NG106)
This guideline covers diagnosing and managing chronic heart failure in people aged 18 and over. It aims to improve diagnosis and treatment to increase the length and quality of life for people with heart failure.
Evidence-based recommendations on DyeVert Systems for reducing the risk of acute kidney injury in coronary and peripheral angiography.
Our centralised approach to prioritising our guidance topics ensures that we produce guidance that's relevant, timely, accessible, and has demonstrable impact.